Effect of the mTOR Inhibitor Everolimus on Angiogenic Biomarkers in Patients with Skin Lesions and Subependymal Giant Cell Astrocytoma (SEGA) Associated with Tuberous Sclerosis Complex (TSC)

被引：0
|
作者：
Franz, D. N.
Frost, M. N.
Prestifilippo, J.
Brechenmacher, T.
Jozwiak, S.
机构：
来源：
ANNALS OF NEUROLOGY | 2013年 / 74卷
关键词：
Brain tumors/oncology; Genetics;
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：S135 / S135
页数：1
相关论文
共 50 条
  • [21] DOSE-LEVEL RESPONSE RATES OF MTOR INHIBITION IN TUBEROUS SCLEROSIS COMPLEX (TSC) RELATED SUBEPENDYMAL GIANT CELL ASTROCYTOMA (SEGA)
    Weidman, D.
    Bouffet, E.
    Taylor, M.
    Bartels, U.
    PEDIATRIC BLOOD & CANCER, 2013, 60 : 136 - 136
  • [22] Dose-level response rates of mtor inhibition in tuberous sclerosis complex (TSC) related subependymal giant cell astrocytoma (SEGA)
    Weidman, Danielle R.
    Pole, Jason D.
    Bouffet, Eric
    Taylor, Michael D.
    Bartels, Ute
    PEDIATRIC BLOOD & CANCER, 2015, 62 (10) : 1754 - 1760
  • [23] Everolimus for Subependymal Giant Cell Astrocytoma (SEGA) Associated with Tuberous Sclerosis Complex (TSC): EXIST-1 long-term efficacy and safety results
    Franz, D. N.
    Belousova, E.
    Sparagana, S.
    Bebin, E. M.
    Frost, M.
    Kuperman, R.
    Witt, O.
    Kohrman, M. N.
    Flamini, J. R.
    Wu, J. Y.
    Curatolo, P.
    de Vries, P. J.
    Berkowitz, N.
    Anak, O.
    Niolat, J.
    Jozwiak, S.
    ANNALS OF NEUROLOGY, 2014, 76 : S175 - S175
  • [24] Safety of Everolimus by Age Category for Subependymal Giant Cell Astrocytoma (SEGA) Associated with Tuberous Sclerosis Complex (TSC): results from the EXIST-1 trial
    Franz, D. N.
    Brechenmacher, T.
    Segal, S.
    Jozwiak, S.
    ANNALS OF NEUROLOGY, 2014, 76 : S179 - S179
  • [25] SUBEPENDYMAL GIANT CELL ASTROCYTOMA (SEGA) IN ADULTS WITHOUT TUBEROUS SCLEROSIS
    Macdonald, D. R.
    MacDonald, M. J.
    Megyesi, J. F.
    Hammond, R. R.
    NEURO-ONCOLOGY, 2016, 18 : 60 - 60
  • [26] EXPLORING RARE CASES OF SUBEPENDYMAL GIANT CELL ASTROCYTOMA (SEGA) IN PATIENTS WITH AND WITHOUT TUBEROUS SCLEROSIS COMPLEX (TSC): EXPERIENCE FROM INDONESIA
    Amal, Mohamad Yanuar
    Rahmartani, Ludi Dhyani
    Susanto, Eka
    NEURO-ONCOLOGY, 2024, 26
  • [27] Gene expression profiling of subependymal giant cell astrocytoma (SEGA) in patients with tuberous sclerosis
    Tyburczy, M. E.
    Kaminska, B.
    Dabrowski, M.
    Kotulska, K.
    Jozwiak, S.
    FEBS JOURNAL, 2007, 274 : 173 - 173
  • [28] EFFECTS: an expanded access program of everolimus for patients with subependymal giant cell astrocytoma associated with tuberous sclerosis complex
    Fogarasi, Andras
    De Waele, Liesbeth
    Bartalini, Gabriella
    Jozwiak, Sergiusz
    Laforgia, Nicola
    Verhelst, Helene
    Petrak, Borivoj
    Pedespan, Jean-Michel
    Witt, Olaf
    Castellana, Ramon
    Crippa, Stefania
    Gislimberti, Gabriella
    Gyorsok, Zsuzsanna
    BMC NEUROLOGY, 2016, 16
  • [29] EverolimusIn Patients with Subependymal Giant Cell Astrocytoma Associated with Tuberous Sclerosis Complex
    Monique P. Curran
    Pediatric Drugs, 2012, 14 : 51 - 60
  • [30] EFFECTS: an expanded access program of everolimus for patients with subependymal giant cell astrocytoma associated with tuberous sclerosis complex
    Andras Fogarasi
    Liesbeth De Waele
    Gabriella Bartalini
    Sergiusz Jozwiak
    Nicola Laforgia
    Helene Verhelst
    Borivoj Petrak
    Jean-Michel Pedespan
    Olaf Witt
    Ramon Castellana
    Stefania Crippa
    Gabriella Gislimberti
    Zsuzsanna Gyorsok
    BMC Neurology, 16
12345